Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Higher pollution levels linked to deteriorating lung health among adult European citizens

New data has identified a clear link between higher levels of exposure to air pollution and deteriorating lung health in adult European citizens. This study confirms previous findings that children growing up in areas with higher levels of pollution will have lower levels of lung function and a higher risk of developing symptoms such as cough and bronchitis symptoms.

6 Sep 2014

Peramivir drug safe, effective at alleviating influenza symptoms

An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor (NAI) peramivir is safe and effective at alleviating influenza symptoms, including fever and viral shedding, when administered within 48 hours of the onset of symptoms.

6 Sep 2014

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

6 Sep 2014

Three Johns Hopkins Medicine hospitals win 2014 Excellence Award for Quality Improvement in Hospitals

Three Johns Hopkins Medicine hospitals have been awarded the 2014 Excellence Award for Quality Improvement in Hospitals from the Delmarva Foundation for Medical Care, an independent, nonprofit health care quality improvement organization.

5 Sep 2014

Researchers investigating new ways to identify drugs against Ebola virus infection

Researchers from the University of Liverpool in collaboration with Public Health England have been investigating new ways to identify drugs that could be used to treat Ebola virus infection.

5 Sep 2014

Avian influenza A H3N8 virus poses threat to humans

A study led by St. Jude Children's Research Hospital scientists found the avian influenza A H3N8 virus that killed harbor seals along the New England coast can spread through respiratory droplets and poses a threat to humans.

5 Sep 2014

University of Leicester researchers uncover new insights into day-length measurement in flies

Researchers from the University of Leicester have for the first time provided experimental evidence for a genetic link between two major timing mechanisms, the circadian clock and the seasonal timer.

5 Sep 2014

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, has released an update on the clinical trial pipeline for its lead immunotherapy products treating basal cell carcinoma (BCC) and breast cancer.

4 Sep 2014

Researchers examine which condition comes first - childhood obesity or asthma?

For years, doctors have known that there is a link between childhood obesity and asthma, but have found it difficult to determine which condition tends to come first, or whether one causes the other.

4 Sep 2014

3 billion people worldwide at risk of early death due to household air pollution

Household air pollution, caused by the use of plant-based or coal fuel for cooking, heating, and lighting, is putting nearly three billion people worldwide at risk of ill health and early death, according to a new Commission, published in The Lancet Respiratory Medicine journal.

4 Sep 2014

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

4 Sep 2014

Project aims at establishing central biobank for development of new drugs

Human stem cells allow scientists to assess how patients are likely to respond to new drugs and to examine how illnesses come about.

4 Sep 2014

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Type 2 diabetes is a major contributor to mortality in patients with bipolar disorder who are admitted to general hospitals, a study shows.

3 Sep 2014

Legatum Foundation donates $150,000 to Ebola Crisis Fund

The Legatum Foundation, the development arm of the Legatum Group, today announced a donation of $150,000 to the Ebola Crisis Fund, a fund established to help prevent the spread of the deadly Ebola virus in West Africa.

3 Sep 2014

Teens and young adults face high risk from opioid-involved overdose

The prevalence of opioid-involved overdoses has become an increasing concern to health officials both in NYC and nationally.

3 Sep 2014

Doctors, retail clinics adopt new business models

The financial ground is changing for doctors in private practice and for patients seeking care. Being a doctor in private practice today is more complicated than it used to be, with growing financial pressures, more government regulation, greater oversight by insurers, rapid developments in medicine and pressure to keep up with technology.

3 Sep 2014

Many nurses in training feel unprepared to meet patients during end-of-life care

Most nurses in their work care for patients who are dying. A study of more than 200 students has shown that many nurses in training feel unprepared and anxious when faced with the prospect of meeting patients during end-of-life care.

3 Sep 2014

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

Antisense Therapeutics Limited is pleased to report the primary efficacy results from its Phase II clinical trial of ATL1103 in patients with the potentially life threatening growth disorder, acromegaly.

2 Sep 2014

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today promising preliminary results from a preclinical study with its ricin toxin vaccine RiVax™, in a non-human primate (NHP) lethal aerosol exposure model.

2 Sep 2014

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Cepheid announced today the release of Xpert® Flu/RSV XC, an on-demand molecular test for rapid, accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection.

2 Sep 2014

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Higher pollution levels linked to deteriorating lung health among adult European citizens

Peramivir drug safe, effective at alleviating influenza symptoms

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Three Johns Hopkins Medicine hospitals win 2014 Excellence Award for Quality Improvement in Hospitals

Researchers investigating new ways to identify drugs against Ebola virus infection

Avian influenza A H3N8 virus poses threat to humans

University of Leicester researchers uncover new insights into day-length measurement in flies

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Researchers examine which condition comes first - childhood obesity or asthma?

3 billion people worldwide at risk of early death due to household air pollution

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Project aims at establishing central biobank for development of new drugs

Type 2 diabetes adds to hospital mortality risk in bipolar patients

Legatum Foundation donates $150,000 to Ebola Crisis Fund

Teens and young adults face high risk from opioid-involved overdose

Doctors, retail clinics adopt new business models

Many nurses in training feel unprepared to meet patients during end-of-life care

ANP reports primary efficacy results from ATL1103 Phase II trial in patients with acromegaly

Soligenix announces promising preliminary results from study on ricin toxin vaccine

Cepheid releases Xpert Flu/RSV XC for accurate determination of Flu A, Flu B and RSV infection

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in